OMEC.AI's mission is to help pharmaceutical companies have better chances in clinical trials by making better data-driven decisions in the pre-clinical process. The company provides an automated, data-focused solution that can produce a reliable assessment of the clinical trial-readiness of a proposed drug. OMEC.AI was established with funding and support from AION Labs, a collaboration between pharmaceutical giants Pfizer, AstraZeneca, Merck, and Teva Pharmaceuticals, together with Amazon's AWS and the Israel Biotech Fund.
Cumulative Funding Raised Over Time ($)
Employees Over Time
OMEC.AI Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 30, 2022
www.tech12.co.il
יוצאת מהגראז': עומק רוצה להעלות את סיכויי הצלחה של...
#Investment, Partners, Expand
Sep 28, 2022
www.timesofisrael.com
Israeli innovation lab backed by pharmaceutical, biotech giants mints 1st AI startup